ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neuropace Inc

Neuropace Inc (NPCE)

13.42
0.43
( 3.31% )
Updated: 14:43:01

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.42
Bid
13.36
Ask
13.54
Volume
47,931
12.94 Day's Range 13.52
3.795 52 Week Range 18.15
Market Cap
Previous Close
12.99
Open
13.03
Last Trade
99
@
13.5
Last Trade Time
14:43:01
Financial Volume
$ 632,205
VWAP
13.1899
Average Volume (3m)
108,473
Shares Outstanding
28,344,637
Dividend Yield
-
PE Ratio
-11.52
Earnings Per Share (EPS)
-1.16
Revenue
65.42M
Net Profit
-32.96M

About Neuropace Inc

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically ... NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Neuropace Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NPCE. The last closing price for Neuropace was $12.99. Over the last year, Neuropace shares have traded in a share price range of $ 3.795 to $ 18.15.

Neuropace currently has 28,344,637 shares outstanding. The market capitalization of Neuropace is $379.82 million. Neuropace has a price to earnings ratio (PE ratio) of -11.52.

NPCE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.36-2.6124818577613.7814.50512.949037113.88411743CS
40.020.14925373134313.415.774712.114578413.74969536CS
12-2.13-13.697749196115.5518.1512.110847314.31289294CS
267.05110.6750392466.3718.156.089389312.44322683CS
529.06207.7981651384.3618.153.7957049710.37459983CS
156-12.17-47.55763970325.5927.381.226800210.99532696CS
260-9.83-42.279569892523.2527.381.227275411.94646593CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.28
(76.60%)
64.03M
SBFMSunshine Biopharma Inc
$ 1.17
(44.91%)
28.41M
NIVFNewGenIvf Group Ltd
$ 1.88
(44.62%)
55.67M
AGENAgenus Inc
$ 11.47
(38.19%)
2.27M
ULHUniversal Logistics Holdings Inc
$ 45.16
(37.31%)
395.18k
MFImF International Ltd
$ 2.38
(-77.20%)
19.83M
NWGLNature Wood Group Ltd
$ 5.945
(-64.72%)
1.84M
ICLKiClick Interactive Asia Group Ltd
$ 1.195
(-52.77%)
664.89k
NUWENewellis Inc
$ 0.17
(-41.18%)
17.42M
SGBXSafe and Green Holdings Corporation
$ 0.1425
(-34.93%)
7.36M
PEGYPineapple Energy Inc
$ 0.06385
(23.03%)
298.61M
SQQQProShares UltraPro Short QQQ
$ 11.425
(-4.79%)
114.02M
INTCIntel Corporation
$ 31.675
(-9.78%)
91.88M
TSLATesla Inc
$ 167.68
(-1.47%)
80.97M
BDRXBiodexa Pharmaceuticals PLC
$ 1.28
(76.60%)
64.03M

Your Recent History

Delayed Upgrade Clock